BRXTX
Price
$20.35
Change
+$0.21 (+1.04%)
Updated
Jun 2 closing price
Net Assets
4.85B
VFWPX
Price
$177.42
Change
+$1.16 (+0.66%)
Updated
Jun 2 closing price
Net Assets
90.68B
Interact to see
Advertisement

BRXTX vs VFWPX

Header iconBRXTX vs VFWPX Comparison
Open Charts BRXTX vs VFWPXBanner chart's image
BRXTX vs VFWPX Comparison Chart in %
View a ticker or compare two or three
VS
BRXTX vs. VFWPX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRXTX is a StrongBuy and VFWPX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFWPX has more cash in the bank: 90.7B vs. BRXTX (4.85B). VFWPX pays higher dividends than BRXTX: VFWPX (2.62) vs BRXTX (1.23). BRXTX was incepted earlier than VFWPX: BRXTX (11 years) vs VFWPX (15 years). BRXTX (0.78) is less costly to investors than VFWPX (0.03). BRXTX is a more actively managed with annual turnover of: 48.00 vs. VFWPX (6.00). BRXTX has a lower initial minimum investment than VFWPX: BRXTX (0) vs VFWPX (100000000). BRXTX annual gain was more profitable for investors over the last year : 34.58 vs. VFWPX (29.36). BRXTX return over 5 years is better than : 62.70 vs. VFWPX (36.28).
BRXTXVFWPXBRXTX / VFWPX
Total Expense Ratio0.770.032,567%
Annual Report Gross Expense Ratio0.780.032,600%
Fund Existence11 years15 years-
Gain YTD16.14814.929108%
Front LoadN/AN/A-
Min. Initial Investment0100000000-
Min. Initial Investment IRAN/AN/A-
Net Assets4.85B90.7B5%
Annual Yield % from dividends1.232.6247%
Returns for 1 year34.5829.36118%
Returns for 3 years84.8260.29141%
Returns for 5 years62.7036.28173%
Returns for 10 years155.41106.34146%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IPHA1.820.04
+2.25%
Innate Pharma SA
LRN97.911.41
+1.46%
Stride
CRCT4.16-0.23
-5.24%
Cricut
RVMD151.30-12.38
-7.56%
Revolution Medicines
HCWB1.79-0.28
-13.53%
HCW Biologics Inc